← Back to patent-cliff list
CAS 1623028-18-1
2-Quinazolinecarboxamide, 4-(2-chlorophenyl)-N-(methyl-11C)-N-[(1R)-1-methylpropyl]-
Codes: [11C]ER-176
Application context (from source-drug indications)
Alzheimer's disease[11C]ER-176Dementia[11C]ER-176
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| [11C]ER-176 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2-aminophenyl)(2-chlorophenyl)methanone→4-(2-chlorophenyl)quinazoline-2-carboxylic acid→(R)-butan-2-amine→(R)-N-(sec-butyl)-4-(2-chlorophenyl)quinazoline-2-carboxamide→2-Quinazolinecarboxamide, 4-(2-chlorophenyl)-N-(methyl-11C)-N-[(1R)-1-methylpropyl]-
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.